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Abstract
Background
Primary health care facilities frequently manage dengue cases on an ambulatory basis for
the duration of the patient’s illness. There is a great opportunity for specific messaging,
aimed to reduce dengue virus (DENV) transmission in and around the home, to be directly
targeted toward this high-risk ambulatory patient group, as part of an integrated approach to
dengue management. The extent however, to which physicians understand, and can them-
selves effectively communicate strategies to stop focal DENV transmission around an
ambulatory dengue case is unknown; the matter of patient comprehension and recollection
then ensues. In addition, the effectiveness of N,N-diethyl-3-methylbenzamide (DEET)-
based insect repellent in protecting dengue patients from Aedes aegyptimosquitoes’ bites
has not been investigated.
Methodology
A knowledge, attitude and practice (KAP) survey, focusing on the mechanisms of DENV
transmission and prevention, was performed using semi-structured questionnaires. This
survey was targeted towards the patients and family members providing supportive care,
and physicians routinely involved in dengue patient management in Southern Vietnam. An
additional clinical observational study was conducted to measure the efficacy of a widely-
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used 13% DEET-based insect repellent to repel Ae. aegyptimosquitoes from the forearms
of dengue cases and matched healthy controls.
Principal Findings
Among both the physician (n = 50) and patient (n = 49) groups there were several respon-
dents lacking a coherent understanding of DENV transmission, leading to some inappropri-
ate attitudes and inadequate acute preventive practices in the household. The application of
insect repellent to protect patients and their relatives frommosquito bites was frequently rec-
ommended by majority of physicians (78%) participating in the survey. Nevertheless, our
tested topical application of 13% DEET conferred only ~1hr median protection time from Ae.
aegypti landing. This is notably shorter than that advertised on the manufacturer’s label. No
differences in landing time between febrile dengue cases or matched healthy controls (n = 19
experiments) were observed.
Conclusion/Significance
Our study identifies missed opportunities for primary care physicians to improve public health
through communication of strategies that could prevent focal dengue transmission in and
around a case household. We advocate better access to more efficient communication
methods for physicians and auxilliary health workers, supporting to educate those at high
risk of DENV transmission. Our empirical testing of a widely-available 13%DEET-based
repellent was limited in its protective efficacy against Ae. aegyptimosquito bites, and there-
fore DENV transmission, suggesting more frequent application is necessary to be beneficial.
Author Summary
In endemic countries many dengue cases are managed on an ambulatory basis throughout
their illness. Many of these ambulatory cases will be infectious to Ae. aegyptimosquitoes
for some period of the febrile phase. A survey of two key actors, physicians who manage
dengue cases and the primary caregiver to dengue cases, was performed to assess their
knowledge, attitudes and practices on the mechanism of DENV transmission and preven-
tion. In addition, the duration of protection from mosquito landing was measured and
compared between febrile dengue patients and healthy volunteers using a locally available,
and widely-used 13% N,N-Diethyl-3-methylbenzamide (DEET)-based topical insect repel-
lent. This KAP survey demonstrated an incomplete understanding of DENV transmission
among several patients and physicians, leading to some inappropriate attitudes and inade-
quate preventive practices in the household. This suggests that aspects of the knowledge,
communication between physicians and patients about dengue, and what patients have
retained from the clinical consultation, can be improved. The use of topical insect repellent
to protect patients and relatives from mosquito bites was recommended by a large propor-
tion of physicians. However, the repellent used in this experiment provided only a modest
repellent effect to Ae. aegyptimosquitoes, with no difference in protection time when
applied to either dengue patients or healthy controls. Future recommendations to patients
should continue to promote repellent use, but advocate much more frequent application.
To directly target those patients at risk of onward DENV transmission, this research high-
lights the potential benefits of physicians imparting practicable and effective advice on
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preventive measures of dengue case management, as part of a holistic approach to dengue
control. Finally, findings of this work can provide data for approaching effectively preven-
tive practices for DENV and other flaviviruses transmitted by Aedes spp.
Introduction
Dengue is the most important arboviral infection of humans globally and is primarily transmit-
ted between humans through the bites of Aedes aegyptimosquitoes [1,2]. It is estimated that
there are approximately 390 million infections annually, and 3.9 billion people living at risk of
dengue virus (DENV) infection [3]. Vietnam is a country with a 50+ year history of sustained
DENV transmission. Dengue epidemics in this country were first reported in 1959 in northern
Vietnam [4]. Since then, Vietnam has become a country with hyperendemic DENV transmis-
sion (i.e.: with the co-circulation of all four serotypes of DENV), and an increasing annual inci-
dence of hospitalized dengue cases throughout the country [5–7]. Dengue prevention has now
entered a new era with a live, attenuated, tetravalent dengue vaccine of Sanofi-Pasteur recently
licensed in Mexico, Brazil and the Philippines. However, in Vietnam and many other countries
where dengue is endemic, the vaccine has not yet been licensed, and mosquito control therefore
remains the mainstay for preventing DENV transmission in the community.
Symptomatic dengue patients had been found to transmit DENV to Aedes spp. mosquitoes
from ~1.5–2 days prior to fever onset until day 3–6 of illness [8–10]. Recently, Nguyet et al.
[11] and Whitehorn et al. [12] have identified the plasma DENV viremia levels in Vietnamese
dengue patients needed to successfully infect 50% of exposed Ae. aegypti or Ae. albopictusmos-
quitoes (50% mosquito infectious dose; MID50). In addition, most ambulatory dengue cases
were revealed to have viremia levels that exceed the MID50 in the first few days of their illness
[11], indicating that most are still infectious to Ae. aegypti when they return to their homes.
Epidemiological studies also confirm the home is a location of risk with respect to DENV
transmission [13,14]. The capacity of asymptomatically-infected individuals to transmit to Ae.
aegypti has been recently highlighted, but more work is needed to understand their prevalence
and importance to the overall epidemiology of dengue [10].
Physicians managing dengue cases in outpatient or primary care settings, are ideally placed
to communicate how best to reduce the risk of DENV in an affected household. Previous stud-
ies have explored the Knowledge, Attitude and Practice (KAP) of communities affected by den-
gue, but surprisingly, such studies have never specifically targeted physicians who manage
cases, nor the affected dengue patients or their primary caregivers [15–22]. A robust under-
standing of how DENV is transmitted between humans, and what interventions can effectively
reduce the risk of further dengue transmission is central to the success of physician-led initia-
tives. An equally important issue is the extent to which patients and their families are able to
understand and act upon the information given by their primary care physicians.
Mosquito repellents containing N,N-Diethyl-3-Methylbenzamide (DEET) are the most
effective insect repellent [23–29]. Dengue patients, like other febrile patients, may be more
attractive to mosquitoes compared to non-febrile individuals due to their higher body tempera-
ture, and therefore higher production of carbon dioxide and possibly other volatile compounds
[30–32]. As a result, the mosquito repellents may afford reduced protection for febrile dengue
patients compared to healthy individuals.
The aims of this study were a) to describe the general KAP of physicians and patients
regarding dengue and DENV transmission; b) to understand the physicians perception of what
they communicate to patients regarding local prevention of dengue transmission; and c) to
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investigate whether patients understand and recall the information provided by their physi-
cians and then act upon these suggestions. Finally, we aimed d) to determine the efficacy of a
DEET-containing topical mosquito repellent widely-used in Vietnam, and assess whether effi-
cacy differed between febrile dengue patients and non-febrile healthy controls. Findings from
this study can improve dialogue about dengue and DENV transmission between physicians
and their patients, by highlighting barriers in communication and knowledge gaps.
Materials and Methods
Ethical considerations
Protocol and questionnaires of the KAP survey were reviewed and approved by the Ethics
Committee of Hospital for Tropical Diseases (HTD), Ho Chi Minh City, Vietnam (CS/ND/14/
25). This survey was considered low risk, hence did not need formal approval from the Oxford
University Tropical Research Ethics Committee (OxTREC). The topical repellent study was
approved by the Ethics Committee of HTD (CS/ND/12/12) and the OxTREC (OxTREC 66–
11). All patients and healthy volunteers gave written informed consent to participate in the
repellent study.
KAP survey
Participant enrolment for the KAP survey. The KAP survey was targeted toward Viet-
namese physicians and dengue patients or their primary caregivers and was focused on their
understanding of DENV transmission and prevention. The first group of participants were phy-
sicians working in primary care practices or tertiary referral hospitals in Ho Chi Minh City; or
at provincial hospitals in southern Vietnam. All physicians provided consent before participat-
ing in the survey, which was conducted between September and November 2014 either electron-
ically online (https://www.surveymonkey.com), or using a paper-based questionnaire. The
second group consisted of clinically suspected dengue patients or primary caregivers of those
under 15 years old. The patients were identified through their enrolment, between September
and December 2014, into one of two ongoing descriptive studies taking place at the outpatient
departments of Children’s Hospital Number 1 (CH#1), Children’s Hospital Number 2 (CH#2)
or HTD in Ho Chi Minh City, Vietnam. Study staff, blinded to the laboratory diagnostic test
results of patients, contacted eligible patients or caregivers, either via phone calls or in person
when they came back for follow-up between 10 and 14 days after enrolment into one of these
studies, and invited them to participate in the survey. Participants in the patient group provided
verbal consent before responding to the questionnaire. Recruitment for this group was based on
the list of patients who came back for follow-up visit, and the availability of human resources.
The responses of all participants (physicians and patients) in this survey were self-reported.
Questionnaires. The semi-structured questionnaires were based on previous KAP surveys,
but were modified to more specifically understand the communication between physicians and
patients about DENV transmission and prevention [17,21,22]. Questionnaires were originally
developed in English. They were then translated into Vietnamese by a bilingual staff member,
and back-translated into English by a professional translator for verification. We pre-tested the
questionnaire on a small number of volunteers to receive feedback on content before they were
finalized.
Topical mosquito repellent study
This observational study assessed the effectiveness of a commercial 13% N,N-Diethyl-
3-methylbenzamide (DEET)-based repellent (“Soffell”, Fountain of Youth, Pty Ltd, Singapore)
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against the landing of Ae. aegyptimosquitoes, on Vietnamese adult febrile dengue patients
compared to adult healthy controls, using an arm-in-cage method [26].
Participant enrolment for the repellent study. Patients admitted to one of two specialist
dengue wards at HTD between October 2013 and December 2014, were eligible for enrolment
if they fulfilled the inclusion and exclusion criteria. Inclusion criteria were a) adult patients
( 18 years of age) admitted within the first 96 hours of fever with clinical suspicion of dengue;
b) a positive NS1 rapid test; and c) written informed consent. The exclusion criteria were a)
pregnancy (either clinically confirmed, or by urine dipstick for human chorionic gonadotropin
hormone); b) patients in intensive care unit or those considered clinically instable by their
attending physician; c) learning disability (or any other condition that might risk the patient’s
ability to give informed and autonomous consent); and d) history of severe dermatological con-
ditions or severe reactions to mosquito bites.
Dengue patients were matched to healthy controls for age (+/- 5 years), sex and body mass
index (BMI) (+/- 2). The inclusion criteria for healthy controls were a) adults (18 years of
age); and b) written informed consent. Exclusion criteria were a) pregnancy; b) current febrile
illness; and c) history of severe dermatological conditions or severe reactions to mosquito bites.
Mosquito exposure. The effectiveness of topical repellent was evaluated using a previously
described, arm-in-cage method (Fig 1) [26]. Repeated brief mosquito exposures (for up to 2
Fig 1. Annotated photos of the “arm-in-cage”method. (A)Mosquito repellent (2 mL) was applied onto all
sides of a single forearm, between the elbow and wrist (repellent-treated arm). The opposite limb had no
repellent applied, and was used as an internal control (repellent free arm). (B) The participant inserted her/his
arms into the two mosquito cages simultaneously. Each cage contained ten Aedes aegyptimosquitoes. (C) A
mosquito (circled) landing on a participant’s arm during an exposure. The arms were exposed for a maximum
of 2 minutes each time. “Landing for 2 seconds” was used as a proxy for mosquito biting. After a mosquito
landed on a participant, they were asked to shake off the mosquito and withdraw their arm from the cage.
Alternatively, the participant withdrew their arms only at the end of the two-minute exposure if there was no
mosquito landing, and the exposure was repeated at the next scheduled interval.
doi:10.1371/journal.pntd.0004667.g001
Roles for Physicians, Primary Caregivers and Topical Repellent in Stopping Dengue Transmission
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004667 May 10, 2016 5 / 20
minutes) were performed following the schedule shown in S1 Fig. The Ae. aegyptimosquitoes
used were field-derived, F3, 4–8 day old females that had not yet been either blood fed or
exposed to any form of insect repellent. The previous parental generation of mosquitoes were
confirmed free of DENV, chikungunya virus, and Japanese encephalitis virus. All mosquitoes
were starved for 16–24 hours prior to the commencement of experiments. Four cages (30 cm x
20 cm x 20 cm), each containing ten Ae. aegyptimosquitoes, were randomly assigned to each
participant (dengue case and matched control). One cage was used for the repellent-free arm
(with the expectation that a mosquito landing would occur within the first two-minute expo-
sure). The other three cages were used for the repellent-treated arm. The randomised use of
these three cages was to reduce any bias associated with using only one cage and to prevent
accumulation of repellent on or around the single cage, which may prolong the real duration of
effectiveness of repellent. Study staff applied 2 mL of repellent onto all sides of a single forearm,
between the elbow and ulnar prominence, for each participant. The forearm on which the
repellent was applied (left or right) was randomised, and could differ between the two partici-
pants in each experiment. No repellent was applied to the opposite limb, which was used as an
internal control for each participant. Tympanic temperature was measured both before the
exposure and at the time of mosquito landing on the repellent-treated arm, for both partici-
pants. Mosquitoes used in each experiment were all killed when the experiments were finished,
and there was no transfer of mosquito cages between participants.
During each 2-minute exposure we used “landing for 2 seconds” as a proxy indicator of
mosquito biting, and therefore landing was taken as “breakthrough” of the repellent effect.
Two observers watched to see if a mosquito landed on participants’ arms. Upon a 2-second
landing, the observers asked participants to shake off the mosquitoes from that arm, and
remove it from the cage. The experiment continued with the other arm until a mosquito landed
on it. Observers used a stopwatch for recording the time taken for a mosquito to land on each
arm, measured to the nearest second.
Data analysis
Baseline characteristics of participants were described with categorical variables presented as
proportion, and continuous variables reported as median (with interquartile range [IQR]).
Responses of physicians and patients for each question were presented as the proportion of
respondents who selected each answer.
The distribution of the time to mosquito-landing in febrile dengue cases and healthy con-
trols, respectively, was estimated using the Kaplan-Meier method. The effectiveness of repellent
for each participant was calculated as the difference in time elapsed at landing of mosquitoes
between the repellent-treated and non-treated arms. The time to landing in the repellent and
the non-repellent arms, respectively, were compared between dengue patients and controls
with a Cox Proportional Hazard regression model. Robust standard errors were used to
account for the matched design. A similar Cox model was used to assess the influence of body
temperature on the time to landing.
All data analyses were performed with the statistical software R, version 3.1.1 (R Foundation
for Statistical Computing, Vienna, Austria).
Results
KAP survey of physicians
A total of 70 physicians were invited to join the survey; 16 declined to participate and four
failed to complete the questionnaire, resulting in 50 questionnaires available for analysis. The
profile of the responding physicians, including their clinical specialties, is shown in Table 1.
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Most physicians said that the primary DENV vector mainly breeds in artificial water containers
(68%), and that an effective vaccine for dengue is not currently available (82%). Interestingly,
seven (14%) physicians thought that Anopheles spp. mosquitoes are the primary vector of
DENV (S1 Information). In addition, 52% of physicians believed that only some serotypes of
DENV could cause disease. Regarding the likelihood of mosquitoes becoming infected with
DENV when blood-feeding on dengue patients, 29 physicians (58%) thought that the mosqui-
toes would immediately become infected with DENV and could transmit the virus to other
people in their next bites, while 14 (28%) thought that the mosquitoes could not be infected if
the concentration of DENV in the patient’s blood was too low. There were 21 (42%) respon-
dents who believed that dengue patients could be infectious to mosquitoes throughout the
febrile phase of their illness, whereas 4 (8%) thought that infectiousness lasted for 1–2 days; 19
(38%) thought it could last for 1–2 weeks and the remaining six respondents (12%) said that
they did not know for how long dengue patients could be infectious to mosquitoes (Fig 2 and
S1 Information).
Almost all respondents stated that dengue was a very important disease in their daily clinical
practice (92%), and believed it was their responsibility to discuss DENV transmission and pre-
vention with patients and caregivers (94%). The majority reported that they routinely provide
specific information regarding how the patient was infected (96%) and how to prevent patients
from receiving further bites from Aedes spp. (82%), as well as how to reduce the risk of DENV
infection for other people living in the same house (88%) (Fig 3). An integrated programme of
interventions comprising use of mosquito bed nets (100%), personal mosquito repellents
(78%), and insecticide spraying of adult mosquitoes (78%) was commonly recommended by
physicians to protect dengue patients from subsequent Aedes spp. bites. In terms of reducing
risk of DENV infection in the household, removing mosquito-breeding sites was the most
common recommendation (98%), followed by avoiding mosquito bites (86%) and killing adult
mosquitoes (82%).
KAP survey of patients and their caregivers
Patients (n = 4) and the primary caregivers of those who were under 15 years of age (n = 47
independent cases) were approached for interview at a median of 14 (IQR = 12–14) days after
Table 1. Demographic characteristics of physicians who responded to the KAP survey.
Characteristics n = 50
Age, years—median (IQR) 43 (33–51)
Male sex, n (%) 28 (56)
Specialty, n (%)
Infectious diseases 12 (24)
Pediatrics 13 (26)
Internal medicine 19 (38)
Others (emergency, dermatology, neurology, neurosurgery) 6 (12)
Frequency of working at outpatient department, n (%)
Every day 11 (22)
One day per week 8 (16)
Two days per week 9 (18)
Three days per week 3 (6)
Four days per week 4 (8)
Others (less than once a week) 8 (16)
doi:10.1371/journal.pntd.0004667.t001
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Fig 2. Survey responses of (A) physicians and (B) patients on general knowledge of DENV tranmission and
prevention. Black bars represent the proportion of responses given by participants, who agreed with the
statement. The light-grey part of each bar represents the proportion of participants, who did not agreed with the
statement. The dark grey bars show the proportion of participants who reported that they did not know the response
to that question.
doi:10.1371/journal.pntd.0004667.g002
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their initial enrolment into one of the two outpatient studies. Survey responses from two par-
ticipants (both of whom were caregivers) were excluded because they did not complete the sur-
vey. Therefore, in total 49 questionnaires were used for further analysis. Baseline
characteristics of respondents in this group are presented in Table 2. Among these 49 patients,
22 (45%) had laboratory confirmation of a DENV infection. The majority of respondents
agreed that dengue is a common disease in Vietnam (82%) and that this disease could be seri-
ous, even life-threatening (96%).
Ninety-six percent of respondents (n = 47) believed that DENV could be transmitted
between humans through mosquito bites, among those 4% (n = 2) believed that DENV are
transmitted by all types of mosquitoes while 9% (n = 4) said that they did not know about this
statement and 87% (n = 41) disagreed with the statement. In regards to knowledge on the
breeding sites of the mosquito vectors, 72% (n = 34) stated they bred primarily in artificial
water containers (Fig 2). A further 60% (n = 28) said the mosquitoes mainly bite humans at
night; only 21% disagreed with this statement (S2 Information), and 77% (n = 36) reported
routinely performing control measures to reduce mosquito abundance within their home (at
least once a week). Killing mosquitoes and removing larval breeding sites were routinely per-
formed by 47.2% of households (S2 Information).
Among all 49 respondents 61% (n = 30) believed that DENV-infected people were not con-
tagious to others through the respiratory tract, i.e. through coughing or sneezing; 2% (n = 1)
believed that this could be another potential mode of DENV transmission in the community,
while the remaining 37% (n = 18) of participants said that they did not know.
Fig 3. Dissemination of information by physicians and recollection of information by patients. The left side of the graph shows the responses
of the physicians when asked if they discuss with their patients certain topics. The right hand side of the graph illustrates whether the patients
understood or recall this same information being given to them during their consultation. (NB: the physicians and patients surveyed are independent;
they did not have consultations with each other). Black and light-grey bars represent the positive and negative responses respectively. A list of
recommendations suggested by physicians can be found in S1 and S2 Information.
doi:10.1371/journal.pntd.0004667.g003
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Understanding the physician-patient interaction
All physicians reported that they delivered information verbally about DENV transmission
and prevention during their medical consultation with patients. Leaflets (44%) and booklets
(4%) were also reportedly used as additional methods. Nonetheless, 56% of physicians (n = 28)
said that they could spend only 1–3 minutes to perform the entire medical consultation,
including discussion of the diagnosis, management and any steps to stop further transmission.
Only 18 (36%) physicians were able to spend more than 3 minutes with each patient. In turn,
most physicians (88%) felt that time was the most common barrier to greater discussion of
DENV transmission and disease prevention. Patients’ perceived levels of interest (36%) and
physicians’ self-confidence (12%) were also considered barriers of disseminating information
between physicians and patients. Moreover, physicians also reported that they lacked the train-
ing on DENV transmission cycle and prevention (n = 1); and that the role of transferring infor-
mation about disease prevention is forgotten during the medical consultation (n = 1) (Fig 4).
Most patients (86%) stated that they had received clear and understandable information
from their physicians about the patient’s health status. Yet a much smaller proportion of
respondents reported not receiving any information about how DENV could be transmitted
between humans (37%), the risk of DENV infection of other members in the home (41%), how
to prevent subsequent mosquito bites to the patient (20%), or how to reduce the risk of DENV
infection to other family members (31%) (Fig 3).
All patients who recalled that a physician had provided recommendations about how to
limit mosquito exposure for the patient reported they had acted upon these suggestions (Tables
3 and 4). In 39 respondents who did not recall receiving suggestions from their physicians,
82% (n = 32) performed actions to prevent the patient from mosquito bites anyway. The use of
mosquito bed nets was the most common action to avoid mosquito bites, taken by 81.5%
(n = 26) of these 32 respondents. Other measures included insecticide sprays, using an electric
bat to kill adult mosquitoes and applying topical insect repellent (Table 3). One family reported
Table 2. Demographic characteristics of participants in the patient group who responded to the KAP
survey.
Characteristics n = 49
Age of respondents, years—median (IQR) 37 (33–41)
Male sex of respondents, n (%) 14 (28)
Respondents group, n (%):
Patients 4 (8)
Caregivers (parents or guardians) 45 (92)
Occupation, n (%):
Vendor 20 (41)
Housework man/woman 12 (24)
Factory worker 12 (24)
Ofﬁce staff 2 (4)
Teacher 1 (2)
Farmer 1 (2)
Others—security guard 1 (2)
Educational level, n (%):
Elementary school 7 (14)
High school 35 (72)
Higher 7 (14)
doi:10.1371/journal.pntd.0004667.t002
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Fig 4. Duration, methods and perceived barriers of communication between physicians and patients
during consultation. (A) The amount of time physicians report to spend with each of their patients to discuss
their illness, during a standard medical consultation. (B)Modes of communication commonly used by
physicians to explain DENV transmission and prevention to their patients. (C) Perceived barriers that
physicians experience when discussing with dengue patients’ families about DENV transmission and its
Roles for Physicians, Primary Caregivers and Topical Repellent in Stopping Dengue Transmission
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that one of the actions they performed to prevent DENV transmission within their house was
to isolate the dengue patient from the other family members.
Effectiveness of topical repellent
The effectiveness of topical insect repellent for preventing Ae. aegypti landing on either dengue
cases or matched healthy controls was investigated. Of the 20 independent mosquito exposure
experiments performed, 19 were assessable, and the baseline characteristics of the participants
are shown in Table 5.
prevention. *Other barriers included the physicians’ feeling they lacked the training on DENV transmission
cycle and prevention; and that the role of transferring information about disease prevention is forgotten during
the medical consultation.
doi:10.1371/journal.pntd.0004667.g004
Table 3. Actions performed in patients’ homes to prevent the patients frommosquito bites. The table shows the number of houses, with and without
having received recommendations from the attending physician, using different methods to prevent the patient in the household being bitten by mosquitoes.
Did your physician suggest speciﬁc actions to stop the patients being bitten
by mosquitoes?
Received recommendations
(n = 10)
Did not receive recommendations
(n = 39)
Number of households reported performing preventive actions,
n (%)
10/10 (100) 32/39 (82.0)
Actions performed:
Mosquito bed net, n (%) 9/10 (90) 26/32 (81.5)
Electronic mosquito bat, n (%) 4/10 (40) 8/32 (25.0)
Insecticidal spraying, n (%) 8/10 (80) 16/32 (50.0)
Mosquito repellent, n (%) 2/10 (20) 4/32 (12.5)
Others(*), n (%) 2/10 (20) 8/32 (25.0)
(*) Other actions include: mosquito repelling coil (n = 3); remove breeding sites of mosquitoes (n = 6); remove breeding sites of mosquitoes and use coil
(n = 1)
doi:10.1371/journal.pntd.0004667.t003
Table 4. Actions performed in patients’ homes to prevent other family members from DENV infection. The table shows the numbers of houses, with
and without having received recommendations from the attending physician, using different methods to prevent other household members from DENV
infection.
Did your physician suggest actions that the household should take to limit
the risk of DENV infection in other family members?
Received recommendations
(n = 15)
Did not receive recommendations
(n = 34)
Number of households reported performing preventive actions,
n (%)
15/15 (100) N/A
Actions performed:
Killing adult mosquitoes, n (%) 9/15 (60.0) N/A
Removing breeding sites, n (%) 6/15 (40.0)
Avoiding mosquito bites, n (%) 13/15 (86.7)
Others(*), n (%) 1/15 (6.7)
(*) Other action includes the isolation of the patient from other family members (n = 1)
doi:10.1371/journal.pntd.0004667.t004
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The effectiveness of 13% DEET-based repellent, as measured by the median difference
between landing times of repellent-treated and non-treated arms, was 49m32s
(IQR = 16m01s–01h19m29s) and 56m43s (IQR = 15m55s–02h20m00s) for healthy controls
and patients, respectively (Fig 5). For the 13% DEET-based repellent arms, there was no signifi-
cant difference in elapsed time to landing between patients versus controls (Hazard ratio 0.71;
95% CI 0.42–1.19; p = 0.20), and in approximately half (11/19, 58%) of the experiments mos-
quitoes landed on the patient’s skin first. There was also no clear evidence that the host’s tym-
panic temperature affected the duration of protection from Ae. aegypti landing, irrespective of
the hosts’ febrile status (Hazard ratio 0.89; 95% CI 0.61–1.29; p = 0.53 per +1°C increase in
tympanic temperature). Further, Ae. aegypti appeared to be similarly attracted to both febrile
dengue patients and healthy controls when no repellent was worn, with a median time to land-
ing of 18s (10s–40s) in the control group versus 28s (17s–44s) in dengue patients (Hazard ratio
of dengue patients vs. control: 0.64; 95% CI 0.36–1.14; p = 0.13).
Discussion
In southern Vietnam, more than 60,000 dengue cases are hospitalized each year [6]. The num-
ber of clinically suspected dengue patients presenting at outpatient clinics, but whose illness
does not warrant hospitalization (and therefore is not mandated for reporting to the Ministry
of Health), is believed to be much higher. Some visits represent the patients’ first contact with
health care services, others represent follow-up visits as part of a clinical management plan. In
principle, physicians engaged in these consultations are superbly placed to deliver messages
that could help stop DENV transmission within an affected household and/or to the surround-
ing community. Yet remarkably, this is to our knowledge, the first reported KAP survey of
both physicians and patients with regard to their understanding of DENV transmission and
prevention. The results demonstrate that a proportion of Vietnamese physicians involved in
dengue case management lack of full understanding of DENV transmission dynamics. For
Table 5. Baseline characteristics of participants in repellent study.
Characteristics Patients
(n = 19)
Healthy controls
(n = 19)
Age, years—median (IQR) 26 (20–33) 30 (28–36)
Male sex, n (%) 7 (37) 7 (37)
BMI, Kg/m2 –median (IQR) 22 (20–26) 21 (20–23)
Ethnicity, n (%)
Vietnamese 19 (100) 17 (89)
Caucasian 0 (0) 2 (11)
Repellent applied to right arm, n (%) 10 (53) 8 (42)
Diagnosis, n (%)
Dengue 16 (84) NA
Dengue with warning signs 3 (16)
DENV serotype, n (%)
DENV-1 10 (53)
DENV-2 0 (0) NA
DENV-3 0 (0)
DENV-4 9 (47)
Tympanic temperature at mosquito release °C—median
(IQR)
38.1 (37.6–38.6) 36.9 (36.6–37.2)
Tympanic temperature at landing °C—median (IQR) 38.2 (37.5–38.4) 36.9 (36.7–37.1)
doi:10.1371/journal.pntd.0004667.t005
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instance, the confusion of Anopheles spp. with Aedes spp. mosquitoes as the primary vector of
DENV; or knowledge of the peak biting times of the Aedes spp. mosquitoes (S1 Information).
As a result, these physicians may disseminate the incorrect information, creating confusion
amongst the community due to different messages provided by health workers in the
Fig 5. Kaplan-Meier curves showing the time-to-landing for mosquitoes on participants’ skin.Curves estimate the
elapsed time to Aedes aegyptimosquito landing on both repellent-free and repellent-treated arms of febrile dengue patients
versus non-febrile healthy controls. No statistical differences were observed between estimates for participant groups for
either treatment group (repellent-treated or repellent-free arms).
doi:10.1371/journal.pntd.0004667.g005
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preventive medicine program, thereby reducing the overall benefit of community-based health
education on dengue control [33].
In Vietnam, the national health system requires that all physicians, both general and special-
ized (in any field), must work at outpatient clinics on rotation. Physicians may also provide
medical consultation at their own private office after their normal working time. As a result,
dengue patients presenting to outpatient clinics may be seen not only by infectious disease spe-
cialists or pediatricians, but by those specializing in internal medicine, emergency medicine or
general practitioners, for example. Such physician demographics were represented in our sur-
vey, with 50% of physicians being specialized in fields other than infectious diseases and pediat-
rics. Accordingly, without a background in infectious diseases or pediatric illnesses, the main
focus of the physician is more likely to be on patients’ immediate well-being as opposed to dis-
semination of public health messages that aim to reduce subsequent transmission. Moreover,
due to the very small number of physicians available to treat a very large number of people
within the general public (only 7.2 physicians (in all fields) per 10,000 population in 2010
[34]), the high case load of suspected dengue patients presenting at the outpatient clinics every
day, and the limited time available to spend with each patient, it is often challenging for physi-
cians to dispense clinical advice, sometimes combined with public health messages about
DENV transmission. Nonetheless, as per the WHO guidelines in dengue diagnosis and treat-
ment [35], each suspected dengue patient, who presents at the outpatient clinics during the
early phase of their illness, should come back for follow-up visits during their illness. Therefore,
these recurrent visits provide additional opportunity for physicians not only to discuss with
patients and caregivers about patients’ illness, but also about how to prevent further DENV
transmission. To assist physicians and other health workers (nurses, assistant physicians) in
meeting these demands, health care services can develop more effective strategies to communi-
cate practical dengue control measures, and make these available to health workers in outpa-
tient clinics, for distribution to members of dengue-affected households. Leaflets and booklets
are useful for communicating clear and succinct information to patients about dengue and
minimizing risk of DENV transmission. Further, this information can be kept on hand, and
used as a reference, encouraging preventive measures to reduce further DENV transmission.
Interestingly however, despite some patients having incomplete knowledge about the specif-
ics of DENV transmission, the majority of patients and their families had an acute awareness
of DENV and knowledge of ways to prevent further transmission in the household. For
instance, misunderstanding about the peak biting times of Ae. aegypti probably explains the
reliance on mosquito bed nets by some families, a practice unlikely to significantly reduce the
risk of being bitten by Ae. aegyptimosquitoes, and therefore the risk of DENV infection, since
these mosquitoes are day-time feeders, with peak biting periods early in the morning and even-
ing before dusk [1]. Yet, most patients reported avoiding mosquito bites and killing adult mos-
quitoes to avoid further DENV transmission.
Despite the finding that majority of physicians reported a sense of responsibility for educat-
ing patients about DENV transmission, more than half of the patients said they did not receive,
could not recall, or apparently misunderstood some specific information from their physicians
during the consultations. Both time constraints, and sometimes a lack of specific knowledge on
DENV transmission among physicians can prevent patients being provided with the required
knowledge to maximize effective vector control in their homes, and hence minimize focal
DENV transmission within households [36]. Support from the health system through provi-
sion and distribution of brochures and leaflets at outpatient clinics may alleviate this problem,
by relaying consistent and accurate advice.
The disparity in the responses of physicians and families about DENV transmission and
prevention is likely due to several factors. First, the physicians were likely to respond to
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questions on their preventive practice based on what they consider to be ideal responses, as
opposed to what they actually do in their daily clinical practice, so these results need to be
interpreted conservatively. Second, these results suggest that patients and families may have
failed to understand or recall all the information presented by their physicians during the con-
sultation. On the other hand, information on DENV transmission and its prevention are also
periodically disseminated to community, especially before and during dengue season, by auxil-
iary health workers at the commune level and preventive medicine centers using posters, bro-
chures, leaflets or multimedia tools (e.g. radio, television). Therefore, even though patients and
their families did not receive any recommendation from their physicians during the medical
consultation, they may voluntarily act to reduce risk of DENV infections in community. Meth-
ods for assessing the behavioral impact of these communication tools, such as the Communica-
tion for Behavioral Impact (COMBI) methodology [37], should be employed to measure the
effectiveness of communication tools that promote vector control behavior in the community.
Participants in the patient group KAP survey were recruited from among subjects already
enrolled into other dengue research studies being conducted by our group; thus dedicated
study physicians (who did not participate in the physician survey) had provided information
about dengue to these participants or their family members during the informed consent pro-
cess less than 2 weeks prior to presentation of our survey. Therefore, the information that
patients received from these study physicians was likely to have been more detailed than that
received by the average patient at a local clinic. Despite this, results indicate that the under-
standing and/or recollection of information disseminated by their physicians during the con-
sultation by patients was incomplete. Further, although the patient responses to the KAP
survey here may not be representative of the general experience of most dengue patients when
seeking treatment, there is no reason to suggest that their motivation to act upon their physi-
cian’s recommendations are any different to the general public. It is important to note that
none of the physicians participating in our survey were involved in either of the two dengue
studies through which we recruited participants into the patient group. A further study with a
larger sample size is needed to better understand the actual situation regarding KAP in differ-
ent health care levels, on dissemination of medical and practical information relating to DENV
infection and transmission.
In the KAP survey, the use of insect repellent was one of the common measures that physi-
cians recommended to their patients to help protect both patients and other relatives in the
household from mosquito bites. Insect repellents have been demonstrated to effectively repel
insects, among which, DEET-based preparations provide the greatest protection [23–29]. In
testing the efficacy of a locally available 13% DEET-based repellent, however, we found no dif-
ference in the duration of protection from the DEET-based repellent between dengue patients
and healthy control participants. This suggests that DENV infection, and the accompanying
fever, does not reduce the repellent’s effectiveness, and personal repellent use by both the den-
gue patient, and people living in the same household, should continue to be a public health rec-
ommendation. This is the first study in which the effectiveness of mosquito repellent on febrile
dengue patients, as compared to healthy controls, has been tested. Although dengue patients in
this study were in days 3–6 of illness, we know that dengue patients can be infectious to mos-
quitoes even in the first days of illness, and before they become symptomatic [8,11]. We there-
fore advocate an integrated approach to stop focal transmission in the home; frequent use of a
topical repellent by the patient will stop new mosquito infections, while killing existing mos-
quitoes (that were potentially already exposed to the virus) can prevent subsequent infections
in naïve human hosts.
The duration of effectiveness of our chosen DEET-based mosquito repellent on non-febrile
healthy participants was shorter than that of other products reported in other studies, as well
Roles for Physicians, Primary Caregivers and Topical Repellent in Stopping Dengue Transmission
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004667 May 10, 2016 16 / 20
as that stated by manufacturer on the product label (up to 10 hours protection) [23–29]. Differ-
ences in formulation and strength are known to alter the protective duration of repellent activ-
ity [38–40]. Variations in efficacy of mosquito repellent may be influenced by a variety of
biological and non-biological factors, such as environmental conditions (light, temperature,
humidity) [41], experimental procedures (repellent dose, exposure time, mosquito cage size)
[42,43], mosquito age, species and strain [44,45]; as well as the attractiveness of individual vol-
unteers [30,31,41,45,46]. Despite this, even with a higher concentration of DEET (13% versus
4.75%), and a larger volume of repellent (2 mL versus 1 mL), the product we used protected
participants from a host-seeking mosquito for a relatively shorter duration (00h49m32s versus
01h28m24s) than the commercial DEET-based repellent (OFF! Skintastic for Kids), reported
in the study of Fradin et al. [26]. The product we tested also provided a considerably shorter
duration of protection (00h49m32s versus 04h00m00s) than a more comparable 15% DEET-
based product (OFF! Active), used by Bissinger et al. [23]. Therefore, while our study advocates
that physicians’ continue to recommend the use of insect repellent to protect dengue patients
as well as other family members from mosquito bites, our data suggest that the frequency of
application should be considerably greater than that stipulated on the label to maintain effec-
tive protection.
In conclusion, our KAP survey highlights the importance of physicians, as well as other
heath care workers, being adequately knowledgeable about dengue and the DENV transmis-
sion cycle, because these data indicate that patients respect, and adhere to the practical advice
provided by their consulting physician. In addition to knowledge gaps among physicians, we
have demonstrated that insufficient consultation time to disseminate information is a common
and important problem. These issues become barriers to what could otherwise be an effective
medium for spreading practical information about preventing DENV transmission to those
who would benefit from it most. The results of this survey can be used to help develop a suit-
able training programme for physicians involved in dengue case management. Patients and
caregivers also failed to recall information from their physicians, likely a result of brief physi-
cian consults and/or ineffective modes of communication. In a region like Southern Vietnam
where DENV is hyperendemic year-round, a combination of targeted messaging, and commu-
nity-wide education campaigns would benefit all community residents. Future surveys should
compare effectiveness of communication methods to enhance the quality and frequency of
interventions that householders can apply to prevent further dengue transmission in their
home and community.
The use of insect repellent was commonly recommended by physicians to protect dengue
patients and their family members from mosquito bites. Our repellent experiments therefore
investigated DEET-based mosquito repellent, and found that it provides similar duration of
protection to febrile and afebrile people against mosquito bites. We advocate that physicians
continue to recommend the application of DEET-based repellent to avoid mosquito bites, how-
ever that this application bemore frequent than that on the manufacturer’s label. This, in con-
junction with active vector control efforts in the home should help to subsequently reduce the
risk of further DENV transmission. Moreover, findings from the KAP survey and mosquito
repellent experiments can also be used to assist developing effectively vector control for DENV
and other flaviviruses transmitted by Aedes spp.
Supporting Information
S1 Fig. Schedule and duration of exposures to Aedes aegyptimosquitoes. Each exposure to a
cage of ten mosquitoes lasted for 2 minutes. If a mosquito failed to land on participants’ skin
(for at least 2 seconds) within the 2 minutes of each exposure, subsequent exposures occurred
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at staggered intervals thereafter. The order of mosquito cages used on the repellent-treated arm
was determined randomly. If the mosquitoes failed to land on the repellent-treated arm after a
maximum of 245 minutes (4 hours and 5 minutes), the experiment was finished, with the data
point for failed landing being ‘censored’ at the 245-minute mark.
(TIF)
S1 Information. Questionnaire for physicians. The correct answers to the questions in the
knowledge theme are highlighted in bold. At the right of each response is the number of partic-
ipants that selected that response, and the associated percentage.
(PDF)
S2 Information. Questionnaire for patients. The correct answers to the questions in the
knowledge theme are highlighted in bold. At the right of each response is the number of partic-
ipants that selected that response, and the associated percentage.
(PDF)
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